LinkMed invests SEK 20 million in AnaMar Medical and IMED

LinkMed has decided to make follow-up investments of SEK 10 million in each of the portfolio companies AnaMar Medical and IMED.

LinkMed is utilizing its option in AnaMar Medical to subscribe to shares for SEK 7.5 million and has also decided to invest a further SEK 2.5 million in share capital. Both of these investments will be made in August. AnaMar Medical’s other principal shareholder, Koncentra Holding, has also promised to contribute a further SEK 2.5 million in share capital. The reason that the owners are reinforcing the company’s financing is that AnaMar Medical is expanding its development programme with both additional and further advanced development projects.

IMED’s principal shareholders, LinkMed and Karolinska Development, through its funds I and II, have decided to contribute SEK 10 million each in a new share issue in August. As a result, LinkMed’s ownership stake in IMED will increase from 39 percent to 42 percent.

For further information contact:
Ingemar Lagerlöf, CEO LinkMed, Tel. + 46 8 50 89 39 93 or ingemar.lagerlof@linkmed.se